Trials / Completed
CompletedNCT01826461
An Evaluation of PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Evaluation of Twice Daily PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate Atopic Dermatitis in Subjects 3 Months to Less Than 18 Years of Age
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 151 (actual)
- Sponsor
- PreCision Dermatology, Inc. · Industry
- Sex
- All
- Age
- 3 Months – 17 Years
- Healthy volunteers
- Not accepted
Summary
This study will compare the safety and efficacy of three test article foams (PDI-192 0.1% Foam, PDI-192 0.15% Foam, and Vehicle Foam) such that a final commercial product may be selected for future development.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PDI-192 | |
| DRUG | Vehicle |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2013-04-08
- Last updated
- 2014-05-29
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01826461. Inclusion in this directory is not an endorsement.